Articles tagged with Cardiovascular Disorders
Researchers have developed an AI-powered algorithm that can detect the risk of atrial fibrillation (AFib) with high accuracy, even in people with infrequent AFib episodes. This new tool has the potential to reduce the incidence of stroke and heart failure by identifying patients at increased risk and guiding targeted interventions.
A vegan diet has been shown to improve cardiovascular health in just eight weeks, according to a study led by Stanford Medicine. The researchers found that participants who followed a vegan diet had lower LDL-C levels, insulin, and body weight compared to those on an omnivore diet.
A study of 438,000 U.S. adults found that smoking cessation can significantly reduce cardiovascular, cancer, and respiratory mortality rates. Within a decade of quitting, former smokers' risk of cardiovascular death was approximately one-third that of continuing smokers.
A new study from Aarhus University found no association between working up to seven night shifts per month and the risk of coronary heart disease. The study, which analyzed data from over 250,000 employees, suggests that international studies may have been flawed due to reliance on questionnaires.
Researchers have identified a new therapeutic target for pulmonary hypertension treatment by discovering an epigenetic pathway mediated via the protein SPHK2 that can reduce and potentially reverse vascular remodeling. This discovery offers new hope for treating pulmonary hypertension, which is a complex and often fatal condition.
A study of US neighborhoods found a strong association between environmental burden and higher rates of cardiovascular risk factors and diseases. Socially vulnerable neighborhoods showed the strongest associations, highlighting the need for initiatives to address poor environmental conditions and improve cardiovascular health.
Patients with heart failure treated with dapagliflozin experienced frequent initial estimated glomerular filtration rate declines, but without increased cardiovascular or kidney event risks. The study suggests that sodium-glucose cotransporter-2 inhibitors can be safely continued in patients experiencing eGFR decline.
A recent clinical trial found that semaglutide significantly reduced cardiovascular events in adults with overweight or obesity who do not have diabetes. The medication was shown to lower the risk of death from cardiovascular causes, nonfatal heart attacks, and strokes by 20% compared to placebo.
A study published in JAHA found that sleep-related hypoxia is associated with a higher risk of developing atrial fibrillation over time. Regular screening and treatment of sleep apnea may help reduce the likelihood of AFib, especially in those already at high risk.
A study published in the European Heart Journal found that replacing sedentary behavior with moderate-vigorous activity reduces the risk of cardiovascular disease. Even small changes, such as taking a short walk or doing some light exercise, can have a significant impact on heart health.
A new study found that workplaces implementing flexible work arrangements can reduce employees' cardiometabolic risk, equivalent to a reduction of 5-10 years in age-related changes. The intervention had no negative impact on productivity and was particularly beneficial for low- and middle-wage workers.
The Canadian Cardiovascular Society has adopted a new classification system for heart attacks based on the extent of tissue damage, which aims to improve patient outcomes by guiding treatment and predicting disease progression. The four-stage classification outlines varying levels of injury following a heart attack.
A new analysis from Penn researchers projects a significant increase in US cardiovascular deaths due to extreme heat over the next four decades. Older adults and Black adults will experience greater increases in excess cardiovascular deaths due to extreme heat, according to the study.
Atrial fibrillation patients undergoing TAVR with the Watchman device had similar outcomes to those receiving medical therapy or blood thinners after TAVR, according to a Cleveland Clinic-led trial. The study found no differences in all-cause death, stroke, and major bleeding between the two groups.
Researchers at The University of Toledo discovered that engineered Lactobacillus paracasei can lower blood pressure in female rats by introducing human ACE2. The study provides a paradigm shift in harnessing the body's microbiome to regulate blood pressure and offers new hope for treating chronic conditions.
A large real-world analysis provides vital insights into the safety of novel therapies for pulmonary embolism. Ultrasound-assisted catheter-directed thrombolysis emerged as the preferred approach due to its lower risk of complications, particularly major bleeding. The study also highlights the importance of individual patient character...
Researchers at Kyushu University have successfully converted brain immune cells into neurons, which restored brain function after a stroke-like injury in mice. The findings suggest that replenishing neurons from immune cells could be a promising avenue for treating stroke in humans.
The Million Hearts Model significantly reduced first-time heart attacks and strokes, supporting guidelines for CVD primary prevention. The study's findings also suggest that the model can have a positive impact on Medicare spending.
A recent NIH grant will support research into the genetic factors contributing to cardiac arrhythmia, a condition affecting millions of Americans. The study aims to identify specific genes linked to arrhythmia risk and develop novel therapeutic approaches.
Researchers developed a calculation to identify moderate aortic stenosis patients at higher risk of mortality. The study found that low mean arterial pressure is associated with higher mortality in all patient subgroups.
A meta-analysis found that CPAP treatment adherence is associated with a lower risk of recurrent cardiovascular events in patients with obstructive sleep apnea. Adherence to CPAP therapy may be a key factor in secondary cardiovascular prevention.
Researchers tracked over 25,000 people using wearables data and found that daily living activities of at least moderate intensity can reduce major cardiac events; longer bouts lasting 5-10 minutes may have comparable health benefits.
A new study from Tulane University found that walking more than five flights of stairs daily can cut the risk of heart disease by 20%. The study, published in Atherosclerosis, used UK Biobank data from 450,000 adults and found that stair climbing reduced cardiovascular disease risk in those with multiple risk factors.
A new study reveals that COVID-19 triggers a dangerous immune response in hardened fatty deposits lining the heart's largest blood vessels. This inflammation can lead to immediate and longer-lasting heart issues, including plaque rupture and blockage of blood flow.
A large study of 74,471 patients found that those who quit smoking after percutaneous coronary intervention (PCI) have comparable rates of heart attacks, strokes, and deaths to non-smokers. However, heavy smokers showed no improvement in cardiovascular outcomes.
Researchers will investigate risk factors for malignant arrhythmias in mitral valve prolapse, aiming to develop novel indicators and improve patient outcomes. The study will use imaging technology and combine it with other markers to predict the development of arrhythmias over a five-year period.
A large study published in Journal of Investigative Dermatology found that patients with severe psoriasis have a high prevalence of coronary microvascular dysfunction, which is associated with increased cardiovascular risk. Psoriasis severity and duration, as well as the presence of psoriatic arthritis, are independently linked to redu...
Researchers found that almond-supplemented diets resulted in significant weight loss and improved cardiometabolic outcomes. The study demonstrated the benefits of nuts as part of a balanced weight loss diet, with almonds providing unsaturated fats that can improve blood cholesterol levels and contribute to a healthy heart.
Researchers identified a stable NO intermediary called NO-ferroheme, which enables nitric oxide to regulate blood flow and blood pressure. The discovery provides strong evidence for the role of heme in stabilizing NO and offers potential for developing new drugs targeting disease states such as pulmonary hypertension and diabetes.
A systematic review found that antidepressants are equally effective and safe for patients with both depression and physical health issues as those without. The study suggests that treating these patients with antidepressants can improve quality of life and reduce the course of physical disease.
A large Kaiser Permanente study found that moderate aortic stenosis patients have similar outcomes to those with mild stenosis. Fine-tuning physician assessment could help identify patients who may benefit from surgery, improving treatment strategies.
A new study from Women's College Hospital and ICES found that older females with atrial fibrillation are at higher stroke risk due to inadequate monitoring and treatment, highlighting sex inequities in cardiovascular care.
A recent study of 31 million pregnant individuals found that infertility treatment is associated with an increased risk of stroke-related hospitalization within 12 months of delivery. The risk was evident as early as 30 days postpartum, highlighting the importance of timely follow-up and long-term monitoring to mitigate stroke risk.
Research from the University of Chicago Medical Center reveals that people who experienced parental incarceration before age 18 had higher levels of hypertension and coronary disease biomarkers. The study's findings suggest that mass incarceration may have transgenerational health consequences.
A nationwide study found that modern blood thinners (NOACs) reduce the risk of serious bleeding by up to 45 percent compared to traditional drug Waran. Apixaban, a NOAC substance, is associated with a lower risk of bleeding in both short and long-term treatment.
A new study found that younger atrial fibrillation (AFib) patients who underwent MRI-guided ablation treatments had better outcomes. The treatment significantly improved arrhythmia recurrence rates by 50% for patients under 58 years old.
The Texas Heart Institute has received a five-year, $2 million grant from the National Institutes of Health to advance organ bioengineering. The project aims to develop transplantable bioartificial hearts to combat end-stage heart failure.
A new study found that catheter ablation significantly lowers the incidence of cardiovascular events and death in very old patients with nonvalvular atrial fibrillation. The researchers compared 208 patients who underwent AF ablation with those who received medical therapy only, finding a lower risk of both cardiovascular events and de...
Researchers at Brigham and Women's Hospital have developed an AI model that screens electrocardiograms (ECG) for signs of atrial septal defects (ASD), a common adult congenital heart disease. The model correctly detected ASD in 93.7% of cases, outperforming traditional methods.
Researchers investigate how exposure to endocrine-disrupting chemicals in plastics may increase atherosclerosis and CVD risk, particularly in children. The study aims to establish a novel therapeutic target for chemical-induced CVD and explore gene-EDC interactions.
A French study found that recreational drug use was associated with a nearly 9-fold higher rate of death or need for emergency intervention in cardiac intensive care patients. The study detected various substances in 1 in 10 patients, with cannabis being the most frequently detected substance.
A new study from Tulane University found that Black adults are 54% more likely to die of cardiovascular disease than White Americans, largely due to social factors. The study's lead author suggests that addressing unemployment, low income, and lack of a partner can help reduce this disparity.
Researchers at City of Hope have identified new molecular targets on a cell receptor that play a major role in cardiovascular regulation. The findings could lead to improved drugs for heart disease, an unfortunate side effect of some cancer therapies.
Researchers found that stable, long-term elevation in urinary albumin excretion is associated with a high risk of new-onset heart failure and mortality. Persistently high levels were linked to older patients and those with conditions like diabetes and previous heart attacks.
Researchers found that people with obstructive sleep apnea have a higher risk of cardiovascular disease, with reduced blood oxygen levels being the leading factor. The study suggests that treating sleep apnea could help prevent future cardiovascular outcomes.
Octapharma's Balfaxar, a prothrombin complex concentrate, has received FDA approval for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy. The product demonstrated effective hemostasis in 94.6% of patients and was non-inferior to comparator Kcentra.
A new diet score reveals that people who follow a more sustainable diet are 25% less likely to die during a 30-year follow-up period. Plant-based foods are associated with lower risks of chronic diseases and reduced environmental impacts.
A study published in Science reveals that ganglia in the neck region are responsible for disrupting melatonin production and causing sleep disturbances in people with heart conditions. Researchers found that macrophages accumulate in the ganglion, leading to inflammation and scarring, which can be treated with drugs.
Rice University scientists use light-activated molecular machines to trigger intercellular calcium signals, revealing a powerful new strategy for controlling cellular activity. The technology could lead to improved treatments for people with heart problems, digestive issues, and more.
OU researchers discovered a correlation between cerebral blood flow regulation and prognosis following cardiac arrest. The study found that detecting this regulatory mechanism can improve management and optimize post-resuscitation care for individual patients.
The inaugural issue of CHEST Critical Care focuses on clinically relevant research and patient management guidance for critical care medicine. The journal accepts submissions of original research, case series, and research letters, covering topics such as intensive care medicine and diverse populations.
A new study published in JAMA found that bempedoic acid can reduce major adverse cardiovascular events in high-risk primary prevention patients who cannot tolerate recommended doses of statins. The treatment has the potential to improve outcomes for these patients, providing a new option for primary prevention.
Head and neck squamous cell carcinoma patients face substantial burden of uncontrolled cardiovascular risk factors, leading to increased risk of stroke and heart attack. Modifiable CV risk factor control is crucial in reducing the risk of adverse cardiovascular events and death among these patients.
The USPSTF recommends regular screening for depression in the adult population to address its significant impact on daily functioning. Major depressive disorder can lead to increased mortality if left untreated.
Researchers found that radioactive iodine and thyroidectomy significantly increased survival rates for patients with hyperthyroidism. The treatments were associated with a decreased risk of death compared to antithyroid drugs, and had varying effects on weight gain.
A new analysis of the CLEAR Outcomes Trial found that bempedoic acid lowered LDL cholesterol levels by 21% and reduced cardiovascular events by 13%. This suggests that different classes of cholesterol drugs have similar benefits for cardiovascular health.
Researchers found that high-fat diets increase levels of gut-derived bacterial toxins and systemic inflammation, promoting atherosclerosis. The study suggests targeting interventions for individuals at risk of developing heart disease.
Researchers at the Lewis Katz School of Medicine found that calcium sensor MICU1 regulates mitochondrial ultrastructure, governing inner and outer mitochondrial membrane structure. This discovery provides a framework for understanding cellular energetics and cell death, with implications for diseases such as cardiovascular disease.
The Texas Heart Institute and The University of Texas at Austin receive a four-year, $2.37 million NIH grant to develop injectable hydrogel electrodes for preventing and managing ventricular arrhythmias. Researchers have already demonstrated the feasibility of pacing the heart using the hydrogel in a porcine model.
A new study reveals delayed diagnosis of HoFH leads to premature cardiovascular disease, highlighting the need for increased lipid screening and aggressive treatment. Despite available therapies, most patients require further lipid-lowering treatments.